share_log

Tonix Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MORRIS JESSICA EDGAR

SEC announcement ·  Mar 1 06:10
Summary by Futu AI
Jessica Edgar Morris, the Chief Operating Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was involved in a transaction on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Morris is closely watched by investors for insights into executive confidence and potential future performance of the company's stock.
Jessica Edgar Morris, the Chief Operating Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was involved in a transaction on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Morris is closely watched by investors for insights into executive confidence and potential future performance of the company's stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.